Latest Breaking News On - Barbara burtness - Page 1 : comparemela.com

Vaccinex : ASCO Conference Presentation - MarketScreener

Correlative and spatial biomarker analysis of a phase 1/2b study to evaluate PEPINEMAB IN COMBINATION WITH PEMBROLIZUMAB for first-linetreatment.

New research and treatment advances from Yale Canc

New Research and Treatment Advances From Yale Canc

Georgetown Lombardi Visiting Professor and Grand Rounds Lecture Series: "Synthetic Lethal Therapy for HPV-Negative Head and Neck Cancer"

Title: “Synthetic Lethal Therapy for HPV-Negative Head and Neck Cancer” Presented by: Barbara Burtness, MD Professor of Medicine, Department of Medical Oncology Yale School of Medicine Location: New Research Building Auditorium with Zoom option Lecture Series Presented by Georgetown Lombardi Comprehensive Cancer Center  About the Speaker: Barbara Burtness, MD, is professor of medicine (Medical Oncology) […]

VIC-1911 With/Without Sotorasib Under Investigation in KRAS G12C Inhibitor–Resistant and –Naïve NSCLC

Sarah Goldberg, MD, MPH, highlights the mechanism of action of VIC-1911, expands on its ongoing investigation in the phase 1 trial, and sheds light on next steps planned for the agent’s investigation in KRAS G12C–mutant non–small cell lung cancer.